IRLAB Therapeutics AB
STO:IRLAB A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IRLAB Therapeutics AB
STO:IRLAB A
|
SE |
|
Adverum Biotechnologies Inc
NASDAQ:ADVM
|
US |
|
ERI Holdings Co Ltd
TSE:6083
|
JP |
|
P
|
Prime Road Power PCL
SET:PRIME
|
TH |
|
Predator Oil & Gas Holdings PLC
LSE:PRD
|
JE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IRLAB A's stock price target?
Not Available
IRLAB A doesn't have any price targets made by Wall Street professionals.
What is IRLAB Therapeutics AB's Revenue forecast?
Projected CAGR
-17%
For the last 9 years the
compound annual growth rate for
IRLAB Therapeutics AB's revenue is
95%.
The projected
CAGR
for the next 1 year is
-17%.